Heat Shock Protein 70 (Hsp70) Peptide Activated Natural Killer (NK) Cells for the Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC) after Radiochemotherapy (RCTx) – From Preclinical Studies to a Clinical Phase II Trial
H. Specht, N. Ahrens, C. Blankenstein, T. Duell +15 more
2015Frontiers in Immunology99 citations Open access
Semantic Scholar

